The panel will feature subject matter experts exploring public funding, private investment, and navigating the UK’s regulatory landscape.
Speakers
Diana is an Investment Principal at LifeArc Ventures, where she leads investments and supports portfolio companies across biotech and medical devices. She brings eight years of operational experience from a medical software scale-up, alongside a strong venture capital background. Among others, Diana has invested in and served on the board of Robeauté, a pioneering brain microrobotics company. Previously, she was a Principal at Apex Ventures and Chief Scientific Alliance Officer at Image Analysis Group, an AI imaging company serving biopharma. She holds a PhD in neuroimaging software and an MSc in medical computer science
Gillian, a bioengineer, is passionate about advancing health through neurotechnology. She brings expertise in neuromodulation product development and biomaterials from her time at Blackrock Neurotechnology and Imperial College London.
Darius is a Master's scholar in Biomedical Engineering at Imperial, with a love for community-building and unbridled passion for neurotech — thus co-leading the 1600-member Imperial Neurotech Society, which has massively expanded beyond a student-scope into Europe's largest of its kind since launching in 2024. His personal hype? Ultrasonic neuromodulation.
The panel will feature subject matter experts exploring public funding, private investment, and navigating the UK’s regulatory landscape.
Speakers
Diana is an Investment Principal at LifeArc Ventures, where she leads investments and supports portfolio companies across biotech and medical devices. She brings eight years of operational experience from a medical software scale-up, alongside a strong venture capital background. Among others, Diana has invested in and served on the board of Robeauté, a pioneering brain microrobotics company. Previously, she was a Principal at Apex Ventures and Chief Scientific Alliance Officer at Image Analysis Group, an AI imaging company serving biopharma. She holds a PhD in neuroimaging software and an MSc in medical computer science
Gillian, a bioengineer, is passionate about advancing health through neurotechnology. She brings expertise in neuromodulation product development and biomaterials from her time at Blackrock Neurotechnology and Imperial College London.
Darius is a Master's scholar in Biomedical Engineering at Imperial, with a love for community-building and unbridled passion for neurotech — thus co-leading the 1600-member Imperial Neurotech Society, which has massively expanded beyond a student-scope into Europe's largest of its kind since launching in 2024. His personal hype? Ultrasonic neuromodulation.